RSV prefusion F protein — Drug Target

All drugs that target RSV prefusion F protein — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Viral vector vaccine

Phase 3 pipeline (1)

• Ad26.RSV.preF-based vaccine · Janssen Vaccines & Prevention B.V. · Viral vector vaccine · Immunology / Infectious Disease
  An adenovirus serotype 26 (Ad26)-based vaccine expressing the respiratory syncytial virus (RSV) prefusion F protein to elicit immune responses against RSV infection.